These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26459517)

  • 21. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
    Webster JD; Yuzbasiyan-Gurkan V; Kaneene JB; Miller R; Resau JH; Kiupel M
    Neoplasia; 2006 Feb; 8(2):104-11. PubMed ID: 16611403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
    Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
    Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor.
    Sulce M; Marconato L; Martano M; Iussich S; Dentini A; Melega M; Miniscalco B; Riondato F
    Vet J; 2018 Dec; 242():15-23. PubMed ID: 30503539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
    De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
    Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation and methylation status of KIT and TP
    Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J
    Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
    Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
    Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
    Hämäläinen S; Kareinen L; Sukura A; Kareinen I
    Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
    Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
    BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
    Gentilini F; Turba ME; Dally C; Takanosu M; Kurita S; Bonkobara M
    BMC Vet Res; 2020 Feb; 16(1):64. PubMed ID: 32075643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
    Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
    Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.
    Harding K; De Mello Souza CH; Shiomitsu K; Maxwell E; Bertran J
    Can J Vet Res; 2021 Oct; 85(4):279-284. PubMed ID: 34602732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.
    Dos Anjos DS; Civa PAS; Werner J; Vicente IST; Fonseca-Alves CE
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.
    Patruno R; Marech I; Zizzo N; Ammendola M; Nardulli P; Gadaleta C; Introna M; Capriuolo G; Rubini RA; Ribatti D; Gadaleta CD; Ranieri G
    Biomed Res Int; 2014; 2014():730246. PubMed ID: 24900982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.